Department of Pediatrics, Pediatrics Endocrinology and Diabetes Section, Yale School of Medicine, New Haven, Connecticut.
Department of Woman's and Child's Health, University of Padova, Padova, Italy.
J Clin Endocrinol Metab. 2020 Feb 1;105(2):534-42. doi: 10.1210/clinem/dgz207.
The time-to-glucose-peak following the oral glucose tolerance test (OGTT) is a highly reproducible marker for diabetes risk. In obese youths, we lack evidence for the mechanisms underlying the effects of the TCF7L2 rs7903146 variant on glucose peak.
We analyzed the metabolic phenotype and the genotype for the TCF7L2 rs7903146 in 630 obese youths with normal (NGT) and impaired (IGT) glucose tolerance. Participants underwent a 3-hour, 9-point OGTT to estimate, using the oral minimal model, the disposition index (DI), the static (φstatic) and dynamic (φdynamic) components β-cell responsiveness and insulin sensitivity (SI). In a subgroup (n = 241) longitudinally followed for 2 years, we estimated the effect of time-to-glucose-peak on glucose tolerance change.
Participants were grouped into early (<30 minutes) and late (≥30 minutes) glucose peakers. A delayed glucose peak was featured by a decline in φstatic (P < .001) in the absence of a difference in φdynamic. The prevalence of T-risk allele for TCF7L2 rs7903146 variant significantly increased in the late peak group. A lower DI was correlated with higher glucose concentration at 1 and 2 hours, whereas SI was inversely associated with 1-hour glucose. Glucose peak <30 minutes was protective toward worsening of glucose tolerance overtime (odds ratio 0.35 [0.15-0.82]; P = .015), with no subjects progressing to NGT or persisting IGT, in contrast to the 40% of progressor in those with late glucose peak.
The prevalence of T-risk allele for the TCF7L2 rs7903146 prevailed in the late time-to-glucose peak group, which in turn is associated with impaired β-cell responsiveness to glucose (φ), thereby predisposing to prediabetes and diabetes in obese youths.
口服葡萄糖耐量试验(OGTT)后达到血糖峰值的时间是糖尿病风险的一个高度可重现的标志物。在肥胖的年轻人中,我们缺乏 TCF7L2 rs7903146 变异对葡萄糖峰值影响的机制的证据。
我们分析了 630 名糖耐量正常(NGT)和受损(IGT)的肥胖青少年的 TCF7L2 rs7903146 代谢表型和基因型。参与者接受了 3 小时 9 点 OGTT,使用口服最小模型估计了处置指数(DI)、静态(φstatic)和动态(φdynamic)β细胞反应性和胰岛素敏感性(SI)成分。在一个随访 2 年的亚组(n = 241)中,我们估计了葡萄糖达峰时间对葡萄糖耐量变化的影响。
参与者被分为早期(<30 分钟)和晚期(≥30 分钟)葡萄糖达峰者。葡萄糖达峰延迟的特征是φstatic 下降(P <.001),而φdynamic 无差异。TCF7L2 rs7903146 变异的 T 风险等位基因在晚期达峰组中的患病率显著增加。较低的 DI 与 1 小时和 2 小时的血糖浓度升高相关,而 SI 与 1 小时的血糖呈负相关。葡萄糖达峰时间<30 分钟对葡萄糖耐量随时间恶化具有保护作用(比值比 0.35 [0.15-0.82];P =.015),与葡萄糖达峰时间较晚的患者相比,没有患者进展为 NGT 或持续 IGT,而葡萄糖达峰时间较晚的患者中有 40%进展为这些患者。
TCF7L2 rs7903146 的 T 风险等位基因在晚期葡萄糖达峰时间组中更为普遍,这反过来又与葡萄糖刺激的β细胞反应受损(φ)有关,从而易患肥胖青少年的糖尿病前期和糖尿病。